Amwill Health Care Ltd

Amwill Healthcare IPO

Amwill Health Care Ltd

₹1,26,000 /1200 sharesMinimum investment

IPO details

Minimum investment
₹1,26,000
Price range
₹105 - ₹111
Lot size
1,200
Issue size
59.98 Cr
Face value
10
IPO document

Subscription rate

Qualified Institutional Buyers7.80x
Non-Institutional Investor5.64x
Retail Individual Investor4.40x
Total5.29x
As of 07 Feb'25, 05:00 PM

Schedule

5 Feb 2025
IPO open date
7 Feb 2025
IPO close date
10 Feb 2025
Allotment date
10 Feb 2025
Funds unblock or debit
12 Feb 2025
Tentative listing date

About

Amwill Healthcare is a derma-cosmetic development company and is involved in the formulation of dermatological, cosmeceutical, and aesthetic products. By collaborating with contract manufacturers, distributors, and third-party development agencies, the company claims to have built on its manufacturing, packaging, and distribution capabilities. The company’s primary focus is on creating dermatological solutions, with all efforts directed toward product formulation and development. The company's product portfolio is categorised into two segments: Development and contract manufacturing of generic dermatological solutions and formulation of targeted solutions for specific dermatological concerns.;
Founded in
2017
MD/CEO
Mr. Anand Gandhi and Mr. Tarun Gandhi
Parent organisation
Amwill Health Care Ltd

Amwill Healthcare Financials

Revenue
Total Assets
Profit
All values are in ₹ Cr
18.0027.6130.17202120222023

Strengths & Risks

Strengths
Risks
The company offers a range of products addressing various dermatological issues, including hair care, skin care, and lip care. Its portfolio includes solutions for acne, ageing, fungal infections, allergies, excessive perspiration, skin lightening, specialised hair care, antioxidants, scar treatment, peri-orbital hyperpigmentation, vitiligo, and steroid and keratolytic treatments.
To maintain high-quality standards, the company claims to conduct thorough testing of its formulations through contract manufacturers. This ensures the final product meets the required molecular composition, texture, fragrance, and overall effectiveness. Additionally, prototypes are reviewed by dermatologists to verify their efficacy before launch.
The company has seen a consistent increase in revenue from operations. Revenue from operations increased from Rs 18.00 crore in FY22 to Rs 27.61 crore in FY23 to Rs 30.17 crore in FY24.
The company relies entirely on Amderma Healthcare LLP, a promoter group entity, for storing, delivering, and distributing its products. This entity accounted for Rs 35.44 crore (99.02%) of revenue in the nine months ending December 31, 2023, and Rs 29.63 crore (98.24%), Rs 24.89 crore (90.15%), and Rs 16.41 crore (91.18%) in FY23, FY22, and FY21, respectively. Any failure to meet contractual obligations or operational disruptions in this partnership could negatively impact the business performance and revenue of the company.
The company depends on third-party contract manufacturers for production. Any decline in product quality, delays in delivery, or an increase in manufacturing costs could disrupt operations and affect overall performance.
A major portion of revenue comes from a limited number of products. The top 10 products contributed Rs 10.92 crore (30.51%) in the nine months ending December 31, 2023, and Rs 9.16 crore (30.36%), Rs 7.45 crore (27.00%), and Rs 4.92 crore (27.32%) in FY23, FY22, and FY21, respectively, to the revenue from operations. Any decline in the sales, pricing, or market demand for these products could adversely affect the company’s operations and finances.
Business operations are concentrated in Karnataka, Andhra Pradesh, and Telangana. Any adverse developments in these regions could negatively affect overall operations and financial performance.
The company reported a loss of Rs 1 crore in FY21. Any future losses could further strain operations and financial health.

Application details

For Amwill Healthcare IPO, eligible investors can apply as Regular.

Apply asPrice bandApply rangeLot size
Regular₹105 - ₹111₹2 - ₹5 Lakhs1200
High Networth Individual₹105 - ₹111₹2 - ₹5 Lakhs1200

Frequently Asked Questions